Gates Foundation pledges $120 million to COVID-19 pill

Name: Gates Foundation pledges $120 million to COVID-19 pill
Uploaded: 2021-10-21T14:58:50Z
Duration: 25 s
Description: The Bill and Melinda Gates Foundation says it will spend $120 million to boost access to generic versions of drugmaker Merck’s antiviral COVID-19 pill for lower income countries, if the drug gets approved by regulators.

The Bill and Melinda Gates Foundation says it will spend $120 million to boost access to generic versions of drugmaker Merck’s antiviral COVID-19 pill for lower income countries, if the drug gets approved by regulators.

Posted October 21, 2021 7:58am PDT